SIRT5 and cancer: In comparison with the control vector and SIRT5 H158Y groups, cell inhibition rate analysis showed that cancer cells overexpressing SIRT5 WT demonstrated a significantly higher survival rate on 5-FU treatment (Fig. 8c).